Publication - 11/22/2013

FDA Final Guidance on Mobile Medical Applications

Life Sciences Now

On September 23, 2013, the FDA issued a guidance (“Final Guidance”) explaining how medical device regulations will be applied to medical mobile applications (MMAs). The Final Guidance provides mobile application manufacturers with recommendations on how to comply with the regulatory and statutory requirements governing medical devices. The Guidance indicates that the FDA intends to limit its enforcement authority to only those mobile applications that operate as medical devices and pose a significant risk to patients if they fail to function as intended.

The Final Guidance outlines three categories of mobile applications (mobile apps) generally: (1) mobile apps that are not medical devices as defined under the Federal Food, Drug, and Cosmetic Act and are therefore not subject to FDA regulation; (2) mobile apps that may meet the definition of a medical device but over which the FDA intends to exercise enforcement discretion because these applications pose a low risk to the public; and (3) mobile apps that meet the definition of a medical device and which the FDA will regulate due to the significant potential risk to patient safety.

To read the entire article, click here.

01/26/2015

Proposed Personal Data Notification & Protection Act

Client Alert
Kenneth K. Dort

01/26/2015

Communications Network Transitions and Next Generation 911: What You Need to Know About the FCC’s Proposed New Federal Framework

Client Alert
Laura H. Phillips

01/22/2015

IRS Finalizes Regulations Under Section 501(r)

Health Care Insight
Linda S. Moroney, Taylor A. Romigh, T.J. Sullivan

01/21/2015

Your Printing Paper Could Get A Lot More Expensive

Client Alert
Richard P. Ferrin, Douglas J. Heffner

01/20/2015

California Labor Laws for the New Year: What Employers need to Know

California CPA
Mark E. Terman